Summary
Health Canada approved two generic versions of Ozempic (semaglutide) in April–May 2026 — making Canada the first G7 country to do so. The generics are clinically identical to Ozempic and are available at Canadian pharmacies from $88–$114/month, compared to $250–$500 for brand-name Ozempic. With telehealth options bundling the consultation and medication from $114/month, the cost of GLP-1 treatment has dropped significantly for Canadians.
Is 'Generic Ozempic' Really the Same Drug?
Yes — unambiguously. Health Canada only approves a generic drug after the manufacturer proves bioequivalence to the brand-name product. Bioequivalence means the same active ingredient (semaglutide), the same dose, delivered at the same rate into the bloodstream. Your body cannot tell the difference between Apo-Semaglutide, Dr. Reddy's semaglutide, and brand-name Ozempic. The clinical effect — on blood sugar, on weight, on appetite — is identical. The pen device may look different and the packaging is different, but the molecule entering your body is the same. Side effects occur with the same frequency and severity. If you switch from Ozempic to a generic, you do not need to re-titrate — your current dose applies directly.
Key point: Health Canada's bioequivalence requirement means generic semaglutide is the same drug as Ozempic. The pen looks different. The drug is not.
Which Generic Versions Are Available in Canada?
Two generics have been approved and are on pharmacy shelves as of June 2026:
**Apo-Semaglutide** (by Apotex, Canada's largest domestic pharmaceutical company) — approved May 1, 2026. Available in 0.25mg, 0.5mg, and 1mg doses as a weekly subcutaneous injection.
**Dr. Reddy's Semaglutide Injection** — approved April 28, 2026, the first generic semaglutide ever approved in a G7 country.
Both are manufactured under Health Canada's pharmaceutical good manufacturing practices (GMP) and have passed full bioequivalence trials. Health Canada is currently reviewing eight additional submissions from manufacturers including Sandoz, Teva Canada, and Vimy Pharma. Each new generic that enters the market increases price competition and will push costs down further.
How Much Does Generic Ozempic Cost in Canada?
This depends on whether you have a prescription already and how you get it.
**Retail pharmacy (bring your own Rx):** The public drug plan price ceiling with two generics approved is approximately $114/month for a four-week supply. Some pharmacies are pricing below this ceiling — pharmacies have been observed charging $88–$110/month, particularly for the 0.5mg starting dose. Call ahead to confirm pricing at your specific location.
**Telehealth + medication bundles (no Rx needed):**
- **PocketPills** — $114/month all-in: online consultation, prescription, and medication delivered free to your door. No dispensing fee. Currently the cheapest all-in option.
- **Hims & Hers Canada** — $149/month all-in: virtual care team, prescription, and medication.
- **Felix Health** — approximately $150/month all-in: physician consultation and medication.
- **Phoenix Health** — price-matching generics (approximately $114/month) with consultation included.
**What about future pricing?** Under Canada's generic drug pricing rules, the price ceiling drops again when three or more generics are approved. With 8+ submissions under review, analysts project the retail price will fall to $70–$90/month once the market reaches three to five competing generics — expected by Q4 2026 or early 2027.
**Brand-name Ozempic for comparison:** $250–$500+/month out of pocket depending on dose and pharmacy. Provincial drug plans cover it for Type 2 diabetes, not weight loss.
Key point: Generic semaglutide costs $88–$114/month at retail, or from $114/month all-in with telehealth. Prices will drop further as more generics enter the market.
Where to Get Generic Ozempic in Canada: Full Comparison
**Online/mail-order with consultation (no Rx needed):**
- PocketPills (pocketpills.com): $114/mo — cheapest all-in, free delivery all provinces, no dispensing fees
- Hims & Hers Canada (hims.com/ca): $149/mo — all provinces
- Felix Health (felixforyou.ca): ~$150/mo — all provinces
- Phoenix Health (phoenix.ca): ~$114/mo price-matched — all provinces
- Maple (getmaple.ca): $69 one-time consult + pharmacy separately — only telehealth covering Quebec and NB
**Retail pharmacy (bring your own Rx):**
- Shoppers Drug Mart: $88–$114/mo, in-stock at most locations
- Rexall: $114/mo, most locations
- London Drugs: $114/mo, BC/AB/SK/MB only
- Costco Pharmacy: competitive pricing, Costco membership required
All locations require a valid Canadian prescription. The telehealth platforms above include the prescription as part of their service. Call your local pharmacy to confirm current stock and pricing before making a trip — inventory varies by location.
Does Your Provincial Drug Plan Cover Generic Ozempic?
Provincial drug plans cover semaglutide for **Type 2 diabetes only** — not for weight loss. The same condition applies to the generics. If you have a T2D diagnosis and are currently covered for Ozempic under your provincial plan, the generic will be covered under the same criteria once it's added to the formulary. If your goal is weight loss without a T2D diagnosis, out-of-pocket cost applies.
**Province-by-province status (June 2026):**
**Ontario (ODB):** Ozempic already covered for T2D under Limited Use code. Generic formulary addition expected within 30–60 days of approval. Copay: $2/Rx for social assistance recipients, $6.11 for seniors.
**BC (PharmaCare):** Covered under Special Authority for T2D. Generic will require a new SA application once listed. Expected within 60–90 days.
**Alberta (Supplemental Health Benefits):** Listed on Alberta Drug Benefit List for T2D. Generic expected within 60 days.
**Quebec (RAMQ):** Covered for T2D under médicament d'exception. Generic listing expected Q3 2026 — RAMQ has a slower process than other provinces.
**Manitoba, Saskatchewan, Atlantic provinces:** Covered for T2D. Generic formulary additions expected within 60–120 days.
**Private insurance:** Varies by plan. Call your benefits provider and ask specifically whether 'semaglutide injection for weight management' is a covered benefit. Some employer plans cover GLP-1s for obesity; most do not.
Key point: Provincial drug plans cover generic semaglutide for Type 2 diabetes. No province covers it for weight loss. Check your province's formulary for current listing status.
Generic Ozempic vs. Wegovy vs. Mounjaro: Which Is Right for You?
These three drugs are often discussed together but they serve different purposes at different price points.
**Generic semaglutide (generic Ozempic, 1mg):** The cheapest option at $88–$114/month. Approved for Type 2 diabetes; prescribed off-label for weight loss. Average weight loss in studies: 8–10% of body weight at the 1mg dose. Weekly injection.
**Wegovy (semaglutide 2.4mg, brand-name):** Health Canada-approved specifically for weight management in adults with obesity. Uses the same molecule as Ozempic but at a higher dose. Average weight loss: approximately 15% of body weight over 68 weeks — meaningfully more than the 1mg generic dose. Cost: $400–$600/month brand-name. No generic equivalent approved in Canada yet (expected 2027 at earliest).
**Mounjaro (tirzepatide, brand-name):** A dual GIP/GLP-1 receptor agonist — different molecule from semaglutide. Health Canada-approved for Type 2 diabetes. Shows 20–22% average weight loss in trials, outperforming both Ozempic and Wegovy. Cost: approximately $400–$500/month. No generic available in Canada.
**Practical guidance:** If cost is the primary concern, start with generic semaglutide at 1mg. If you evaluate at 3 months and need more efficacy, discuss escalating to Wegovy with your doctor. Mounjaro is the most effective but also brand-name-only and expensive. A family physician, nurse practitioner, or telehealth provider can help you decide.
How to Switch from Ozempic to Generic Semaglutide
Switching is straightforward because the drugs are bioequivalent — you don't re-titrate and your current dose applies directly.
**Step 1: Check your prescription.** In most Canadian provinces, pharmacists can substitute an approved generic for the brand-name product unless the prescription says 'no substitution.' Ask your pharmacist: 'Can you dispense the generic semaglutide instead?' If yes, no new prescription is needed.
**Step 2: If a new prescription is needed**, contact your prescribing physician and ask them to write 'semaglutide injection [dose] once weekly — generic preferred' without specifying the Ozempic brand.
**Step 3: Check your coverage.** If your drug plan covers Ozempic, it may or may not yet cover the generic. Ask your pharmacist to run a coverage check. If the generic isn't listed yet, you can either wait (most provinces are updating within 60–90 days) or fill the generic at out-of-pocket price ($88–$114/mo) in the interim.
**Step 4: Learn the new pen.** The generic pen device differs from the Ozempic FlexTouch. Ask your pharmacist to walk you through it on your first fill. The injection site (abdomen, thigh, upper arm) and technique are identical.
🍁 What This Means for Canadians
Canada's position as the first G7 country to approve generic semaglutide created a unique window for Canadian patients. The approval was triggered by Novo Nordisk inadvertently allowing a key Canadian patent to lapse by failing to pay a $250 maintenance fee. This regulatory gap allowed Apotex and Dr. Reddy's to move quickly. The pan-Canadian Pharmaceutical Alliance (pCPA) framework sets the generic price ceiling automatically when two or more generics are approved — this is why the $114/month price is consistent across provinces. When a third generic is approved, the ceiling drops again, and so on. For the approximately 8 million Canadians living with obesity and the estimated 3+ million with Type 2 diabetes, generic semaglutide represents the most significant improvement in GLP-1 drug accessibility since these medications were first approved.
Compare Every Generic Semaglutide Option in Canada
Our Generic Semaglutide Tracker shows live pricing across 10+ Canadian pharmacies and telehealth providers — retail and all-in options, updated weekly.
Information on this page is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any healthcare decisions.